Advertisement

Topics

for Cancer Genetics, Inc. Company Profile

15:29 EST 15th December 2018 | BioPortfolio

Cancer Genetics, Inc. (CGI) is an emerging leader in the field of personalized medicine, offering products and services that enable cancer diagnostics as well as treatments that are tailored to the specific genetic profile of the individual patient. CGI is committed to maintaining the standard of clinical excellence through its investment in outstanding facilities and equipment. Our reference laboratory is both CLIA certified and accredited by the College of American Pathologists. In addition, we have approvals and accreditations from the states of Florida, Maryland, New York, and New Jersey. The company has been built on a foundation of world-class scientific knowledge and IP in solid and hematologic cancers, as well as strong research collaborations with major cancer centers such as Cleveland Clinic and the National Cancer Institute.


News Articles [2252 Associated News Articles listed on BioPortfolio]

Cancer Genetics, NovellusDx agree to merge

Cancer Genetics will be the surviving entity and expects to remain listed on the Nasdaq Stock Market. This transaction will combine Cancer Genetics’ scale, expansive test portfolio and The post Can...

Cancer Genetics Merges With NovellusDx

Two companies with similar oncology goals, Cancer Genetics and NovellusDx, have signed a definitive merger agreement, announced Tuesday. The post Cancer Genetics Merges With NovellusDx appeared first ...

Cancer Genetics Closes $2.625 million Convertible Note Financing

Cancer Genetics (NASDAQ:CGIX) has announced the closing of a $2.625 million convertible note financing with a single institutional investor. As quoted in the press release: John A. Roberts, Chief Exec...

Using genetics to close the knowledge gap on cancer causation

Dr Paul Brennan spoke to ecancer at the UICC World Cancer Congress in Kuala Lumpur about using genetics to close the knowledge gap about cancer causes. He discusses how lifestyle factors are a huge p...

Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge

Cancer Genetics (Nasdaq:CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and NovellusDx, a leader in functional genomi...

Cancer Genetics and Genecast Partner on Gene Test

Cancer Genetics announced on Thursday that it has partnered with China-based Genecast Biotechnology to market, distribute and sell the Tissue of Origin test in China. The post Cancer Genetics and Gene...

Quiz: Understand the Genetics of Skin Cancer

What role do genetics play in skin cancer? Test your knowledge with our latest quiz, while learning more about gene mutations.

GSK Buys Tesaro For $5 Billion In Dramatic Bet On Cancer Genetics

The deal is a dramatic bet that the London-based drug giant can see opportunities connected to the genetics of cancer drugs better than the stock market. It fits into a framework outlined in July by H...

PubMed Articles [6644 Associated PubMed Articles listed on BioPortfolio]

DNA breakpoint assay reveals a majority of gross duplications occur in tandem reducing VUS classifications in breast cancer predisposition genes.

Gross duplications are ambiguous in terms of clinical interpretation due to the limitations of the detection methods that cannot infer their context, namely, whether they occur in tandem or are duplic...

Prevalence of hereditary cancer susceptibility syndromes in children with cancer in a highly consanguineous population.

Hereditary cancer susceptibility syndromes (HCSS) are reported in up to one-third of children with cancer. Diagnosis of HCSS is crucial for implementation of surveillance protocols. We identified chil...

Genetics is the logic of life (at least of mine).

I retrace my path from math to medicine to biochemistry to yeast genetics, my focus on infectious diseases of yeast and finally prions. My discovery of yeast prions relied on my particular focus on th...

DNA methylation haplotypes as cancer markers.

The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers.

The Catalogue of Somatic Mutations in Cancer (COSMIC) Cancer Gene Census (CGC) is an expert-curated description of the genes driving human cancer that is used as a standard in cancer genetics across b...

Clinical Trials [9085 Associated Clinical Trials listed on BioPortfolio]

Virtual Reality Intervention in Cancer Genetics

The goal of this study is to evaluate a virtual reality-based intervention for training health care providers who are not genetics specialists to effectively communicate with and counsel p...

Genetics Education: Preparing Physicians for the Future

This study examines the best way to teach genetics to family medicine residents. First year family medicine residents at the University of Toronto will be taught basic clinical genetics as...

Experiences of Genetics Patients With Visible Abnormalities Who Facilitate Teaching in Genetics Clinics

This study will describe the experience of patients with visible physical abnormalities in the genetics clinic when they are involved in teaching others about their condition. Information ...

Genetics Tests : How to Improve Management Within Two Medical Specialities

This survey will assess discrepancies between official clinical genetics guidelines and practices within 3 West regions of France.

Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)

The goal of this research study is to test the effects of online genetic education alone or in combination with telephone genetic counseling in order to compare the two methods and the str...

Companies [1486 Associated Companies listed on BioPortfolio]

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, couns...

Genetics & IVF Institute

Genetics & IVF was the first U.S. center to introduce non-surgical ultrasound guided egg retrieval for IVF Genetics & IVF achieved America's first frozen embryo twin birth Genetics & IVF was the first...

Ambry Genetics Corporation

Ambry Genetics is a privately held healthcare company with the industry’s most comprehensive suite of genetic testing solutions, benefiting 90% of all U.S. patients covered b...

Interleukin Genetics, Inc.

Interleukin Genetics, Inc. (OTCQB: ILIU) develops and markets a line of genetic tests under the Inherent Health® brand. The products empower individuals to prevent ce...

deCODE genetics Inc.

In January 2006 deCODE GENETICS Inc., acquired Urdur Verdanki Skuld, a privately-held cancer research firm. The acquisition enables deCODE to broaden and enhances its cancer program by applying deCODE...

More Information about "for Cancer Genetics, Inc." on BioPortfolio

We have published hundreds of for Cancer Genetics, Inc. news stories on BioPortfolio along with dozens of for Cancer Genetics, Inc. Clinical Trials and PubMed Articles about for Cancer Genetics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of for Cancer Genetics, Inc. Companies in our database. You can also find out about relevant for Cancer Genetics, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record